Adrian Zelazny
Overview
Explore the profile of Adrian Zelazny including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
661
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bao D, Maity S, Zhan L, Seo S, Shu Q, Lyon C, et al.
EMBO Mol Med
. 2025 Mar;
PMID: 40038396
Mycobacterial infections pose a significant global health concern, requiring precise identification for effective treatment. However, diagnosing them is challenging due to inaccurate identifications and prolonged times. In this study, we...
2.
Youn J, Walker L, Carlson S, Soutar C, Frank K, Zelazny A, et al.
J Clin Microbiol
. 2024 Jun;
62(7):e0041624.
PMID: 38842311
No abstract available.
3.
Cheng A, Kashyap A, Salvator H, Rosen L, Colby D, Ardeshir-Larijani F, et al.
N Engl J Med
. 2024 Mar;
390(12):1105-1117.
PMID: 38507753
Background: Autoantibodies against interleukin-12 (anti-interleukin-12) are often identified in patients with thymoma, but opportunistic infections develop in only some of these patients. Interleukin-12 (with subunits p40 and p35) shares a...
4.
Tunesi S, Zelazny A, Awad Z, Mougari F, Buyck J, Cambau E
Clin Microbiol Infect
. 2023 Oct;
30(6):718-725.
PMID: 37797824
Background: Mycobacterium abscessus (MAB) is the mycobacterial species least susceptible to antimicrobials. Infections are difficult to treat, and cure rates are below 50% even after a combination of 4-5 drugs...
5.
Blakney R, Ricotta E, Frankland T, Honda S, Zelazny A, Mayer-Barber K, et al.
Emerg Infect Dis
. 2022 Jul;
28(8):1543-1550.
PMID: 35876462
To further clarify differences in the risk for nontuberculous mycobacterial pulmonary infection (NTM-PI) among ethnic populations in Hawaii, USA, we conducted a retrospective cohort study among beneficiaries of Kaiser Permanente...
6.
Ning B, Youngquist B, Li D, Lyon C, Zelazny A, Maness N, et al.
Cell Rep Methods
. 2022 Feb;
2(2):100173.
PMID: 35156077
SARS-CoV-2 variants of concern (VOCs) that increase transmission or disease severity or reduce diagnostic or vaccine efficacy continue to emerge across the world. Current methods available to rapidly detect these...
7.
Yang D, England M, Salvator H, Anjum S, Park Y, Marr K, et al.
mBio
. 2021 Oct;
12(5):e0270821.
PMID: 34700378
The Cryptococcus gattii species complex has often been referred to as a primary pathogen due to its high infection frequency among apparently immunocompetent patients. In order to scrutinize the immune...
8.
Manion M, Lynn N, Pei L, Hammoud D, Laidlaw E, Roby G, et al.
Clin Infect Dis
. 2021 Jan;
72(2):315-318.
PMID: 33501968
Mycobacterium genavense is a challenging opportunistic pathogen to diagnose and manage in patients with human immunodeficiency virus (HIV). Persistent immunosuppression or protracted immune reconstitution inflammatory syndrome can lead to complicated...
9.
Church D, Cerutti L, Gurtler A, Griener T, Zelazny A, Emler S
Clin Microbiol Rev
. 2020 Sep;
33(4).
PMID: 32907806
This review provides a state-of-the-art description of the performance of Sanger cycle sequencing of the 16S rRNA gene for routine identification of bacteria in the clinical microbiology laboratory. A detailed...
10.
Dean S, Ricotta E, Fintzi J, Lai Y, Kadri S, Olivier K, et al.
Emerg Infect Dis
. 2020 Aug;
26(9):2243-2246.
PMID: 32818422
We studied 31 US healthcare facilities to characterize trends in mycobacterial testing. During 2009-2015, testing for acid-fast bacilli increased 3.2% annually, and prevalence of pathogenic nontuberculous mycobacteria increased 4.5% annually....